Genetics of cerebral venous thrombosis

Journal of the Pakistan Medical Association

Volumn 56, Issue 11, 2006, Pages 488-490

  Ahmad, Arsalan ^a  

^a SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; ANTITHROMBIN III; APOLIPOPROTEIN A; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRILLIN 1; GLOBIN; HEPARIN COFACTOR II; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR DERIVATIVE; PROTHROMBIN; VON WILLEBRAND FACTOR;

ANTITHROMBIN III DEFICIENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; HUMAN; HYPERHOMOCYSTEINEMIA; OCCLUSIVE CEREBROVASCULAR DISEASE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; THROMBOPHILIA; VEIN THROMBOSIS; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; GENETICS; MUTATION; PATHOLOGY; RISK FACTOR;

CEREBRAL VEINS; HUMANS; INTRACRANIAL THROMBOSIS; MUTATION; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; VENOUS THROMBOSIS;

EID: 33847389354     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, et al. Prognosis ofCerebral vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-70
2. Egeberg O. Inherited antithrombin III deficiency causing thrombophilias. Thromb Diath Haemorrh 1965; 13:516-30
3. Beck EA, Charache P, Jackson DP. A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore'). Nature 1965; 208:143-5.
4. Griffin JH, Evatt B, Zimmermann TS, Kleiss AJ, Wideman C. Defiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-3.
5. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial defiency of protein S. N Engl J Med 1984;311:1525-8.
6. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilias: a complex genetic disorder. Semin Hematol 1997; 34:256-64.
7. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, De Ronade H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
8. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
9. Allan H Ropper, Robert H Brown Ed. Adams and Victor's Principles of Neurology. Eighth edition Mc Graw-Hill, New York, USA 2005; PP 709.
10. Reich LM, Bower M, Key NS. Role of the Genetist in testing and counseling for inherited thrombophilias. Gene Med. 2003;5:133-43.
11. Derex L, Philippeau F, Nighoghossian N, Trouillas P. Postpartum cerebral venous thrombosis, congenital protein C deficiency, and activated protein C resistance due to heterozygous factor V Leiden mutation. J Neurol Neurosurg Pshychiatry 1998;65:801-2.
12. Vandenbroucke JP, Koster T, Briet E, Reitsma PH,Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-7.
13. Seligsohn U,Lubetsky A. Genetic Susceptibility to Venous thrombosis. N Engl J Med, 2001;2441222-31.
14. Martinelli I, Sacchi E,Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral venous thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med, 1998; 338:1793-7.
15. Curry CJ, Holmes J, Catts ZA, et al. Hypercoaguable factors in pregnancy loss and neonatal stroke. Proc Greenwood Gen Ctr 2001. 20:92-3.
16. Mercuri E, Cowan F, Gupte G, Manning R, Laffan M, Rutherford M, et al. Prothrombotic disorders and abnormal neurodevelopment outcome in infants with neonatal cerebral infarction. Pediatrics 2001. 107:1400-4.